Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375843 · ClinicalTrials.gov registry record · Phase 4
Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
A Phase 4 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 4
- Development phase
- 118
- Enrollment target
NCT00375843 is a Phase 4 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 118 participants.
The verdict
NCT00375843, a Phase 4 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 118 participants
- Enrollment target
Study Summary
This study will examine how brain activity is affected by antidepressant treatment and how changes in brain activity relate to treatment response in people with depression.
Interventions
- DRUG Escitalopram
- DRUG Sertraline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 118 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375843
The ClinicalTrials.gov registry entry for NCT00375843 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 118 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Mental Health (NIMH), which has 343 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Escitalopram is the first listed.
NCT00375843 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375843 about?
NCT00375843 is a clinical study titled "Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication". This study will examine how brain activity is affected by antidepressant treatment and how changes in brain activity relate to treatment response in people with depression.
What is the current status of trial NCT00375843?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 118 participants. The study started on 2005-01. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00375843?
The interventions under investigation include: Escitalopram (DRUG), Sertraline (DRUG).
Who is sponsoring clinical trial NCT00375843?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.